Bexsero 0.5 (Meningococcal vaccine PFS) 0.5ml

Bexsero 0.5ml is a meningococcal vaccine designed to protect against invasive meningococcal disease caused by serogroups B, C, W, and Y. Store between 2-8°C to maintain potency. This prefilled syringe (PFS) form offers convenient administration for immunization.

Strength

0.5ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Glaxosmithkline

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bexsero 0.5ml is used to help prevent meningococcal disease, a serious bacterial infection affecting the brain and spinal cord. It is recommended for individuals at increased risk, including travelers to high-risk areas and those with certain medical conditions. The vaccine targets serogroups B, C, W, and Y, which are common causes of invasive meningococcal infections.

Side Effects

After vaccination with Bexsero 0.5ml, the immune system produces antibodies to fight meningococcal bacteria. Common effects include mild pain or redness at the injection site, fatigue, and mild fever. These effects typically resolve within a few days and indicate the body’s immune response.

Precautions & Warnings

Keep Bexsero 0.5ml refrigerated between 2-8°C and avoid freezing. Do not use if the vaccine has been frozen or exposed to higher temperatures. Before administration, check the syringe for particles or discoloration. Inform your healthcare provider of any allergies or previous reactions to vaccines.

Avoid Interactions

Bexsero 0.5ml may interact with immunosuppressive therapies, reducing its effectiveness. Concomitant use with other vaccines should be spaced appropriately unless advised otherwise by a healthcare professional. Avoid alcohol or other substances that may impair immune response during vaccination.

Frequently Asked Questions

Bexsero 0.5ml is a vaccine used to help prevent meningococcal disease caused by serogroups B, C, W, and Y.

Store Bexsero 0.5ml between 2-8°C and avoid freezing to maintain its effectiveness.

Concomitant use with other vaccines may be possible but should be determined by a healthcare professional.

Common effects include pain at the injection site, fatigue, and mild fever, which usually resolve quickly.

Individuals with severe allergies to any component of the vaccine should avoid it unless cleared by a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.